Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Sell
29
DSGN Quote, Financials, Valuation and Earnings
Last price:
$4.23
Seasonality move
:
-15.97%
Day range:
$4.10 - $4.28
52-week range:
$3.15 - $7.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.99x
Volume:
48.3K
Avg. volume:
159.9K
1-year change:
4.47%
Market cap:
$239M
Revenue:
--
EPS (TTM):
-$0.88
Earnings Data
Next earnings date for DSGN
May 08
2025
Most recent earnings per share
-$0.24
Beat by $0.03
(Mar 10/2025)
Consensus Estimate
-$0.27
(Mar 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DSGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/08/2025 | Q1 | -- | -- | -- | -$0.28 | -- |
| 03/10/2025 | Q4 | -- | -- | -$0.24 | -$0.27 | $0.03 |
| 11/07/2024 | Q3 | -- | -- | -$0.23 | -$0.24 | $0.01 |
| 08/05/2024 | Q2 | -- | -- | -$0.21 | -$0.23 | $0.02 |
| 05/08/2024 | Q1 | -- | -- | -$0.20 | -$0.26 | $0.06 |
| 03/19/2024 | Q4 | -- | -- | -$0.21 | -$0.32 | $0.11 |
| 11/13/2023 | Q3 | -- | -- | -$0.28 | -$0.42 | $0.14 |
| 08/14/2023 | Q2 | -- | -- | -$0.36 | -$0.40 | $0.04 |
| 05/09/2023 | Q1 | -- | -- | -$0.35 | -$0.35 | -- |
| 03/14/2023 | Q4 | -- | -- | -$0.31 | -$0.35 | $0.04 |
| 11/03/2022 | Q3 | -- | -- | -$0.32 | -$0.29 | -$0.03 |
| 08/08/2022 | Q2 | -- | -- | -$0.27 | -$0.25 | -$0.02 |
| 05/09/2022 | Q1 | -- | -- | -$0.24 | -$0.22 | -$0.02 |
| 03/10/2022 | Q4 | -- | -- | -$0.20 | -$0.23 | $0.03 |
| 11/09/2021 | Q3 | -- | -- | -$0.21 | -$0.13 | -$0.08 |
| 08/09/2021 | Q2 | -- | -- | -$0.14 | -$0.22 | $0.08 |
| 05/10/2021 | Q1 | -- | -- | -$0.31 | -$0.09 | -$0.22 |
| 12/31/2020 | Q4 | -- | -- | -$0.07 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.05 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.02 | -- | -- |
Design Therapeutics Earnings Questions
-
How Much did Design Therapeutics Generate in Revenue Last Quarter?
Design Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Design Therapeutics Beat Earnings Last Quarter?
Design Therapeutics announced earnings per share of -$0.24 which represents a beat of analyst forecast a -$0.27 per share.
-
Is Design Therapeutics Profitable?
Design Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Design Therapeutics EPS Next Year?
Design Therapeutics's earnings are forecast to decrease from -$0.88 per share to -$1.21 per share next year representing a decrease of -37.5%.
-
When is Design Therapeutics's Earnings Date?
Design Therapeutics's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
